<?xml version="1.0" encoding="UTF-8"?>
<p id="p0195">Most of the patients on systemic immunosuppressive or immunomodulatory therapy included in these studies did not require hospitalization, and death remained a rare outcome. However, systemic corticosteroid use in this patient population appeared to increase the risk of poor outcomes in COVID-19.</p>
